- Home
- CDXS vs MQT Comparison
CDXS vs MQT Comparison
Compare CDXS & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- MQT
- Stock Information
- Founded
- CDXS 2002
- MQT 1992
- Country
- CDXS United States
- MQT United States
- Employees
- CDXS N/A
- MQT N/A
- Industry
- CDXS Major Chemicals
- MQT Investment Bankers/Brokers/Service
- Sector
- CDXS Industrials
- MQT Finance
- Exchange
- CDXS Nasdaq
- MQT Nasdaq
- Market Cap
- CDXS 216.6M
- MQT 222.2M
- IPO Year
- CDXS 2010
- MQT N/A
- Fundamental
- Price
- CDXS $2.56
- MQT $10.06
- Analyst Decision
- CDXS Buy
- MQT
- Analyst Count
- CDXS 2
- MQT 0
- Target Price
- CDXS $11.00
- MQT N/A
- AVG Volume (30 Days)
- CDXS 538.3K
- MQT 52.5K
- Earning Date
- CDXS 10-30-2025
- MQT 01-01-0001
- Dividend Yield
- CDXS N/A
- MQT 4.60%
- EPS Growth
- CDXS N/A
- MQT N/A
- EPS
- CDXS N/A
- MQT N/A
- Revenue
- CDXS $57,164,000.00
- MQT N/A
- Revenue This Year
- CDXS $12.88
- MQT N/A
- Revenue Next Year
- CDXS $21.64
- MQT N/A
- P/E Ratio
- CDXS N/A
- MQT N/A
- Revenue Growth
- CDXS N/A
- MQT N/A
- 52 Week Low
- CDXS $1.90
- MQT $8.59
- 52 Week High
- CDXS $6.08
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- CDXS 51.47
- MQT 60.76
- Support Level
- CDXS $2.41
- MQT $10.03
- Resistance Level
- CDXS $2.73
- MQT $10.17
- Average True Range (ATR)
- CDXS 0.12
- MQT 0.06
- MACD
- CDXS 0.03
- MQT -0.02
- Stochastic Oscillator
- CDXS 55.26
- MQT 58.41
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.